Literature DB >> 6176696

Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines.

E F Hahn, M Carroll-Buatti, G W Pasternak.   

Abstract

Further investigations into the molecular actions of the 14-hydroxydihydromorphinone hydrazones (naloxazone, oxymorphazone, and naltrexazone) have suggested that their irreversible actions can be explained by the formation of their azines. These azines, naloxonazine, naltrexonazine, and oxymorphonazine, irreversibly block opiate binding in vitro 20- to 40-fold more potently than their corresponding hydrozones, naloxazone, naltrexazone, and oxymorphazone. The blockade of binding by naloxonazine shows the same selectivity for high affinity, or mu1, sites as naloxazone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176696      PMCID: PMC6564265     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  20 in total

1.  Involvement of opioid receptor subtypes in both stimulatory and inhibitory effects of the opioid peptides on prolactin secretion during pregnancy.

Authors:  M Soaje; R P Deis
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

Review 2.  Development of delta opioid peptides as nonaddicting analgesics.

Authors:  R S Rapaka; F Porreca
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

Review 3.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

4.  Conformation and electrostatic potential surfaces of opiates: Relationship to µ- and λ-site binding.

Authors:  T P Lybrand; P A Kollman; V C Yu; W Sadée
Journal:  Pharm Res       Date:  1986-08       Impact factor: 4.200

5.  A naloxonazine sensitive (mu1 receptor) mechanism in the parabrachial nucleus modulates eating.

Authors:  Nayla N Chaijale; Vincent J Aloyo; Kenny J Simansky
Journal:  Brain Res       Date:  2008-09-04       Impact factor: 3.252

6.  Genetic dissociation of morphine analgesia from hyperalgesia in mice.

Authors:  Gina F Marrone; Valerie Le Rouzic; Andras Varadi; Jin Xu; Anjali M Rajadhyaksha; Susruta Majumdar; Ying-Xian Pan; Gavril W Pasternak
Journal:  Psychopharmacology (Berl)       Date:  2017-03-25       Impact factor: 4.530

7.  Pronociceptive and Antinociceptive Effects of Buprenorphine in the Spinal Cord Dorsal Horn Cover a Dose Range of Four Orders of Magnitude.

Authors:  Katharina J Gerhold; Ruth Drdla-Schutting; Silke D Honsek; Liesbeth Forsthuber; Jürgen Sandkühler
Journal:  J Neurosci       Date:  2015-07-01       Impact factor: 6.167

Review 8.  Mu opioid receptors in pain management.

Authors:  Gavril Pasternak; Ying-Xian Pan
Journal:  Acta Anaesthesiol Taiwan       Date:  2011-03-17

9.  Activation of the opioid μ1, but not δ or κ, receptors is required for nicotine reinforcement in a rat model of drug self-administration.

Authors:  Xiu Liu; Courtney Jernigan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-10-20       Impact factor: 5.067

10.  Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.

Authors:  L Negri; R Lattanzi; P Melchiorri
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.